IL6 and Castleman disease: It has been associated with autoimmune disorders, lymphoid malignancies, and Castleman disease.[11] But it was not considered as a major pathogenic cytokine in TAFRO syndrome for the absence of some IL-6 associated symptoms (e.g., thrombocytosis and polyclonal hypergammaglobulinemia).